Jane Street’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Jane Street's SMMT Position: Q3 2026 in Review
Jane Street opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 62,553 shares worth $1.06M. The stake represents ﹤0.01% of the portfolio and ranks #6374 among its holdings. This is a return to the name: Jane Street previously reported a position in SMMT as recently as Q2 2025.
Jane Street first reported a position in SMMT in Q4 2021 and has held it in 13 quarters since. The position peaked at $7.69M in Q3 2024. 296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Jane Street held 62,553 shares of Summit Therapeutics worth $1.06M as of Q3 2026.
- Summit Therapeutics was a new Jane Street position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6374 holding.
- Jane Street first reported a position in Summit Therapeutics in Q4 2021 and has held it in 13 quarters since.
- Jane Street's Summit Therapeutics position peaked at $7.69M in Q3 2024.
- 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.